Product Information
METOCLOPRAMIDE 10 MG/2 ML VIAL is a generic product labeled by Teva Parenteral Medicines, Inc., priced at $0.5249 per ML under NDC 00703450204. Its NADAC has been published 172 times since May 18, 2016.
The High Outlier badge above means this manufacturer's average price in the Metoclopramide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/mL
Manufacturer
Teva Parenteral Medicines, Inc.NDC
00703450204
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Last Updated
6/17/2026
Active Ingredients
METOCLOPRAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA073135On Market Since
12/1/1991
Pharmacological Classes
Price Statistics
The NADAC for METOCLOPRAMIDE 10 MG/2 ML VIAL has been published 172 times since May 18, 2016, and over the history we have for it it has risen 4.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5249 per ML |
|---|---|
| All-time high | $0.6016 (May 14, 2025) |
| All-time low | $0.4971 (Jun 19, 2024) |
| 52-week high | $0.5732 |
| 52-week low | $0.5178 |
| Median price | $0.5198 |
| Average price | $0.5382 |
| Largest weekly change | +18.7% (Sep 18, 2024) |
| Weeks tracked | 172 |
| Tracking since | May 18, 2016 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 76% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METOCLOPRAMIDE 10 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for METOCLOPRAMIDE 10 MG/2 ML VIAL, manufactured by Teva Parenteral Medicines, Inc., is $0.5249 per ML (NDC 00703450204), effective Jun 24, 2026.
How has the price of METOCLOPRAMIDE 10 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for METOCLOPRAMIDE 10 MG/2 ML VIAL has risen 4.9%. It has been tracked across 172 weekly CMS publications since May 18, 2016.
What are the highest and lowest recorded NADAC prices for METOCLOPRAMIDE 10 MG/2 ML VIAL?
Since May 18, 2016, the NADAC for METOCLOPRAMIDE 10 MG/2 ML VIAL has ranged from a low of $0.4971 (Jun 19, 2024) to a high of $0.6016 (May 14, 2025), with a median of $0.5198 per ML.
Are there cheaper alternatives to METOCLOPRAMIDE 10 MG/2 ML VIAL?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, METOCLOPRAMIDE 5 MG/5 ML SOLN, is $0.1280 per ML — about 76% below METOCLOPRAMIDE 10 MG/2 ML VIAL.
Who manufactures METOCLOPRAMIDE 10 MG/2 ML VIAL?
METOCLOPRAMIDE 10 MG/2 ML VIAL (NDC 00703450204) is labeled by Teva Parenteral Medicines, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification